Molecular Pathology Approach to Cancer

This conference provides a comprehensive understanding of the scope, methods, future directions, and challenges in molecular pathology, particularly those relating to comprehensive genomic profiling in cancer research and clinical settings. The event focuses on innovative approaches that will empower the next generation of molecular pathologists. Upcoming applications of multiparametric immunoanalysis, liquid biopsy, and AI in pathology will be addressed. Other topics to be covered include comprehensive cancer profiling in diagnostics, novel approaches for developing and implementing biomarkers in both oncology and pathology, and spatial and longitudinal markers for tumor heterogeneity.

Raza Ali (Cancer Research UK Cambridge Institute, UK), Judith V.M.G Bovee (Leiden University Medical Centre, The Netherlands), Lukas Bubendorf (University Hospital Basel, Switzerland), Olli Carpen (University of Helsinki, Finland), Sebastian Foersch (University Medical Centre Mainz, Germany), Mara Graziani (IBM Research, Switzerland), Ellen Heitzer (Medical University of Graz, Austria), Leeat Keren (Weizmann Institute of Science, Israel), Marjolijn Ligtenberg (Radboud University Medical Center, The Netherlands), Ragnhild Lothe (Oslo University Hospital, Norway), Sabine Merkelbach-Bruse (University Hospital Cologne, Germany), Eli Pikarsky (The Hebrew University of Jerusalem, Israel), Hege Russnes (Oslo University Hospital, Norway), Giorgio Stanta (OECI, Italy), Luigi M Terracciano (University Hospital Basel, Switzerland), Kurt Zatloukal (Medical University of Graz, Austria)

Travel grant application deadline: 30 January 2023

Registration deadline: 27 February 2023 

https://www.eacr.org/conference/molecularpathology2023?utm_source=HUM&utm_medium=web&utm_campaign=MP23